Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models ; volume:22 ; number:1 ; day:11 ; month:7 ; year:2022 ; pages:1-15 ; date:12.2022
BMC cancer ; 22, Heft 1 (11.7.2022), 1-15, 12.2022
- Creator
-
Fang, Douglas D.
Tao, Ran
Wang, Guangfeng
Li, Yuanbao
Zhang, Kaixiang
Xu, Chunhua
Zhai, Guoqin
Wang, Qixin
Wang, Jingwen
Tang, Chunyang
Min, Ping
Xiong, Dengkun
Chen, Jianyong
Wang, Shaomeng
Yang, Dajun
Zhai, Yifan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-09799-4
- URN
-
urn:nbn:de:101:1-2022091423062839627492
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fang, Douglas D.
- Tao, Ran
- Wang, Guangfeng
- Li, Yuanbao
- Zhang, Kaixiang
- Xu, Chunhua
- Zhai, Guoqin
- Wang, Qixin
- Wang, Jingwen
- Tang, Chunyang
- Min, Ping
- Xiong, Dengkun
- Chen, Jianyong
- Wang, Shaomeng
- Yang, Dajun
- Zhai, Yifan
- SpringerLink (Online service)
Other Objects (12)
ALK Inhibitors in Nonsmall Cell Lung Cancer
2449
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Grabstein 2449
2400 - 2449
Grabstein 2449
Nr. 2449
Nr. 2449
Nr. 2449
2449 Pasewalk
Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer
scheiss APG
ALK Inhibitors in Nonsmall Cell Lung Cancer
2449
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Grabstein 2449
2400 - 2449
Grabstein 2449
Nr. 2449
Nr. 2449
Nr. 2449
2449 Pasewalk
Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer
scheiss APG
ALK Inhibitors in Nonsmall Cell Lung Cancer
2449
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer
Grabstein 2449
2400 - 2449
Grabstein 2449
Nr. 2449
Nr. 2449
Nr. 2449
2449 Pasewalk
Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer